Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
Key Messages The co-occurrence of psychotic illness and addictive disorders frequently goes unrecognized, with subsequent undertreatment resulting in poor patient outcomes. Cortical/hippocampal dysregulation in patients with schizophrenia may lead to increased positive responses to substances of abuse and a greater susceptibility to addiction. An optimal diagnostic approach for patients presenting with psychosis in the presence…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.